Salmeterol enhances pulmonary fibrinolysis in healthy volunteers

Critical Care Medicine

Volumn 35, Issue 1, 2007, Pages 57-63

  Maris, Nico A ^a   De Vos, Alex F ^a   Bresser, Paul ^a   Van Der Zee, Jaring S ^a   Jansen, Henk M ^a   Levi, Marcel ^a   Van Der Poll, Tom ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

adrenergic agonist; Endotoxins; Hemostasis; Human experimentation; Lung

Indexed keywords

BLOOD CLOTTING FACTOR 7A; LIPOPOLYSACCHARIDE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN C; SALMETEROL; SODIUM CHLORIDE; THROMBIN ANTITHROMBIN COMPLEX; THROMBOMODULIN; THROMBOPLASTIN; UROKINASE;

ADULT; ARTICLE; BLOOD CLOTTING; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; ENZYME ACTIVITY; FIBRINOLYSIS; HUMAN; LUNG HEMODYNAMICS; LUNG LAVAGE; MALE; NORMAL HUMAN; PRIORITY JOURNAL; UNIVERSITY HOSPITAL;

ADMINISTRATION, INHALATION; ADRENERGIC BETA-AGONISTS; ADULT; ALBUTEROL; ANALYSIS OF VARIANCE; BRONCHOALVEOLAR LAVAGE FLUID; BRONCHODILATOR AGENTS; FACTOR VIIA; FIBRINOLYSIS; HUMANS; INFLAMMATION; LIPOPOLYSACCHARIDES; LUNG; LUNG DISEASES; MACROPHAGES, ALVEOLAR; MALE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLASMINOGEN ACTIVATORS; PROTEIN C; SINGLE-BLIND METHOD; THROMBOMODULIN; THROMBOPLASTIN; TISSUE PLASMINOGEN ACTIVATOR; URINARY PLASMINOGEN ACTIVATOR;

EID: 33845914938     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000249827.29387.4E     Document Type: Article

References (41)

1. Gabazza EC, Taguchi O, Tamaki S, et al: Thrombin in the airways of asthmatic patients. Lung 1999; 177:253-262
2. Nakstad B, Lyberg T, Skjonsberg OH, et al: Local activation of the coagulation and fibrinolysis systems in lung disease. Thromb Res 1990; 57:827-838
3. Schultz MJ, Millo J, Levi M, et al: Local activation of coagulation and inhibition of fibrinolysis in the lung during ventilator associated pneumonia. Thorax 2004; 59:130-135
4. Gunther A, Mosavi P, Heinemann S, et al: Alveolar fibrin formation caused by enhanced procoagulant and depressed fibrinolytic capacities in severe pneumonia: Comparison with the acute respiratory distress syndrome. Am J Respir Crit Care Med 2000; 161:454-462
5. Miller DL, Welty-Wolf K, Carraway MS, et al: Extrinsic coagulation blockade attenuates lung injury and proinflammatory cytokine release after intratracheal lipopolysaccharide. Am J Respir Cell Mol Biol 2002; 26:650-658
6. Rijneveld AW, Weijer S, Florquin S, et al: Thrombomodulin mutant mice with a strongly reduced capacity to generate activated protein C have an unaltered pulmonary immune response to respiratory pathogens and lipopolysaccharide. Blood 2004; 103:1702-1709
7. Welty-Wolf KE, Carraway MS, Miller DL, et al: Coagulation blockade prevents sepsis-induced respiratory and renal failure in baboons. Am J Respir Crit Care Med 2001; 164:1988-1996
8. Van der Poll T, Levi M, Nick JA, et al: Activated protein C inhibits local coagulation after intrapulmonary delivery of endotoxin in humans. Am J Respir Crit Care Med 2005; 171:1125-1128
9. Maris NA, de Vos AF, Bresser P, et al: Activation of coagulation and inhibition of fibrinolysis in the lung after inhalation of lipopolysaccharide by healthy volunteers. Thromb Haemost 2005; 93:1036-1040
10. Wygrecka M, Markart P, Ruppert C, et al: Compartment- and cell-specific expression of coagulation and fibrinolysis factors in the murine lung undergoing inhalational versus intravenous endotoxin application. Thromb Haemost 2004; 92:529-540
11. Drake TA, Morrissey JH, Edgington TS: Selective cellular expression of tissue factor in human tissues: Implications for disorders of hemostasis and thrombosis. Am J Pathol 1989; 134:1087-1097
12. Welty-Wolf KE, Carraway MS, Ortel TL, et al: Coagulation and inflammation in acute lung injury. Thromb Haemost 2002; 88:17-25
13. Idell S: Coagulation, fibrinolysis, and fibrin deposition in acute lung injury. Crit Care Med 2003; 31:S213-S220
14. Perkins GD, McAuley DF, Richter A, et al: Bench-to-bedside review: β2-Agonists and the acute respiratory distress syndrome. Crit Care 2004; 8:25-32
15. Kavelaars A, van de Pol M, Zijlstra J, et al: Beta 2-adrenergic activation enhances interleukin-8 production by human monocytes. J Neuroimmunol 1997; 77:211-216
16. Izeboud CA, Mocking JA, Monshouwer M, et al: Participation of beta-adrenergic receptors on macrophages in modulation of LPS-induced cytokine release. J Recept Signal Transduct Res 1999; 19:191-202
17. Houslay MD, Milligan G: Tailoring cAMP-signalling responses through isoform multiplicity. Trends Biochem Sci 1997; 22:217-224
18. Levitzki A: From epinephrine to cyclic AMP. Science 1988; 241:800-806
19. Ollivier V, Houssaye S, Ternisien C, et al: Endotoxin-induced tissue factor messenger RNA in human monocytes is negatively regulated by a cyclic AMP-dependent mechanism. Blood 1993; 81:973-979
20. Crutchley DJ, Hirsh MJ: The stable prostacyclin analog, iloprost, and prostaglandin E1 inhibit monocyte procoagulant activity in vitro. Blood 1991; 78:382-386
21. Heaton JH, Dlakic WM, Gelehrter TD: Posttranscriptional regulation of PAI-1 gene expression. Thromb Haemost 2003; 89:959-966
22. Nonaka T, Matsumoto H, Shimada W, et al: Effect of cyclic AMP on urokinase-type plasminogen activator receptor and fibrinolytic factors in a human osteoblast-like cell line. Biochim Biophys Acta 1995; 1266:50-56
23. Chandler WL, Veith RC, Fellingham GW, et al: Fibrinolytic response during exercise and epinephrine infusion in the same subjects. J Am Coll Cardiol 1992; 19:1412-1420
24. Archipoff G, Beretz A, Bartha K, et al: Role of cyclic AMP in promoting the thromboresistance of human endothelial cells by enhancing thrombomodulin and decreasing tissue factor activities. Br J Pharmacol 1993; 109:18-28
25. Ohashi K, Hirokawa K, Komatsu N, et al: The biosynthesis of thrombomodulin and its enhancement by dibutyryl cAMP in a human megakaryoblastic cell line, UT-7. Int J Hematol 1991; 54:341-349
26. Maruyama I, Soejima Y, Osame M, et al: Increased expression of thrombomodulin on the cultured human umbilical vein endothelial cells and mouse hemangioma cells by cyclic AMP. Thromb Res 1991; 61:301-310
27. Hirokawa K, Aoki N: Up-regulation of thrombomodulin in human umbilical vein endothelial cells in vitro. J Biochem (Tokyo) 1990; 108:839-845
28. Ishii H, Kizaki K, Uchiyama H, et al: Cyclic AMP increases thrombomodulin expression on membrane surface of cultured human umbilical vein endothelial cells. Thromb Res 1990; 59:841-850
29. Ito T, Ogura M, Morishita Y, et al: Enhanced expression of thrombomodulin by intracellular cyclic AMP-increasing agents in two human megakaryoblastic leukemia cell lines. Thromb Res 1990; 58:615-624
30. Maris NA, de Vos AF, Dessing MC, et al: Antiinflammatory effects of salmeterol after inhalation of lipopolysaccharide by healthy volunteers. Am J Respir Crit Care Med 2005; 172:878-884
31. van der Veen MJ, van der Zee JS: Aerosol recovery from large-volume reservoir delivery systems is highly dependent on the static properties of the reservoir. Eur Respir J 1990; 13:668-672
32. van der Veen MJ, Van Neerven RJ, De Jong EC, et al: The late asthmatic response is associated with baseline allergen-specific proliferative responsiveness of peripheral T lymphocytes in vitro and serum interleukin-5. Clin Exp Allergy 1999; 29:217-227
33. Binnema DJ, van Iersel JJ, Dooijewaard G: Quantitation of urokinase antigen in plasma and culture media by use of an ELISA. Thromb Res 1986; 43:569-577
34. Verheijen JH, Mullaart E, Chang GT, et al: A simple, sensitive spectrophotometric assay for extrinsic (tissue-type) plasminogen activator applicable to measurements in plasma. Thromb Haemost 1982; 48:266-269
35. Liaw PC, Ferrell G, Esmon CT: A monoclonal antibody against activated protein C allows rapid detection of activated protein C in plasma and reveals a calcium ion dependent epitope involved in factor Va inactivation. J Thromb Haemost 2003; 1:662-670
36. Thorn J: The inflammatory response in humans after inhalation of bacterial endotoxin: A review. Inflamm Res 2001; 50:254-261
37. Ware LB, Fang X, Matthay MA: Protein C and thrombomodulin in human acute lung injury. Am J Physiol Lung Cell Mol Physiol 2003; 285:L514-L521
38. Levi M, Schultz MJ, Rijneveld AW, et al: Bronchoalveolar coagulation and fibrinolysis in endotoxemia and pneumonia. Crit Care Med 2003; 31:S238-S242
39. Van der Poll T, Levi M, Dentener M, et al: Epinephrine exerts anticoagulant effects during human endotoxemia. J Exp Med 1997; 185:1143-1148
40. Renckens R, Weijer S, de Vos AF, et al: Inhibition of plasmin activity by tranexamic acid does not influence inflammatory pathways during human endotoxemia. Arterioscler Thromb Vasc Biol 2004; 24:483-488
41. Rijneveld AW, Florquin S, Bresser P, et al: Plasminogen activator inhibitor type-1 deficiency does not influence the outcome of murine pneumococcal pneumonia. Blood 2003; 102:934-939